Previous studies have reported that decreased expression of GSTA4 is associated with positive outcomes in glioma models (Cheng et al., 2022), whereas increased expression of GSTA4 promotes the malignant progression of liver cancer (Liu et al., 2017). This evidence concerns the gene GSTA4 and liver cancer.